GSA Capital Partners’s Regulus Therapeutics RGLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-6,471
| Closed | -$45K | – | 1737 |
|
|
2021
Q3 | $45K | Sell |
6,471
-14,156
| -69% | -$98.4K | ﹤0.01% | 1349 |
|
|
2021
Q2 | $168K | Buy |
+20,627
| New | +$168K | 0.02% | 1210 |
|
|
2017
Q4 | – | Sell |
-1,698
| Closed | -$255K | – | 1777 |
|
|
2017
Q3 | $255K | Buy |
1,698
+525
| +45% | +$78.8K | 0.02% | 1333 |
|
|
2017
Q2 | $139K | Buy |
+1,173
| New | +$139K | 0.01% | 1559 |
|
|
2016
Q2 | – | Sell |
-120
| Closed | -$100K | – | 1877 |
|
|
2016
Q1 | $100K | Buy |
+120
| New | +$100K | 0.01% | 1583 |
|
|
2014
Q1 | – | Sell |
-106
| Closed | -$94K | – | 1761 |
|
|
2013
Q4 | $94K | Buy |
+106
| New | +$94K | 0.01% | 1567 |
|